Saliva-derived exosomal CD44v3, a glycoprotein commonly overexpressed in HNSCC tissues (46, 47) and involved in tumor progression (46, 48), and the ectonucleotidase CD39, an enzyme involved in adenosine production (49), were significantly elevated in HNSCC patients. The gene discussed is ENTPD1; the disease is neoplasm.